| 1 |
Therapeutic Efficacy of Piperazine Ferulate Combined With Irbesartan in Diabetic Nephropathy: A Systematic Review and Meta-analysis |
|
| | Dan Li, Bo Li, Li-Xia Peng, Rong Liu, Nan Zeng | | | Clinical Therapeutics. 2020; 42(11): 2196 | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
Renoprotective effects of combining ACE inhibitors and statins in experimental diabetic rats |
|
| | Mudagal, M., Patel, J., Nagalakshmi, N.C., Asif Ansari, M. | | | DARU, Journal of Pharmaceutical Sciences. 2011; 19(5): 322-325 | | | [Pubmed] [Google Scholar] | | | 3 |
Authorsę reply |
|
| | Vaishya, R., Singh, J., Lal, H. | | | Indian Journal of Pharmacology. 2010; 42(3): 197-198 | | | [Pubmed] [Google Scholar] | | | 4 |
Irbesartan in experimental diabetic nephropathy |
|
| | Mahajan, R., Gupta, K., Singh, N.R. | | | Indian Journal of Pharmacology. 2010; 42(3): 197 | | | [Pubmed] [Google Scholar] | |
|
